Sponsor Pipeline

Clarity Pharmaceuticals Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
2
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06056830 Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk… Prostate Cancer Recruiting
NCT06970847 64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With… Prostate Cancer Active, Not Recruiting
Phase 1/2
NCT04868604 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing… Prostatic Neoplasms, Castration-Resistant Recruiting
Disease Areas
Prostate Cancer (2)
Get alerts when Clarity Pharmaceuticals Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free